Photo of Sara Gelser Blouin
D Oregon Senate · District 8 On the 2026 ballot

Sen. Sara Gelser Blouin

Compare
Total votes
6,702
all sessions
Attendance
98%
112 missed
Higher than 83% of chamber peers
With party
99%
of cast votes
Near the chamber average
Bipartisan score
0%
crosses aisle rarely
Near the chamber average
Sponsored
747
bills & resolutions
Near the chamber average
Committees
4
assignments
747 bills and resolutions

Sponsored bills

Total
747
Primary
362
Co-sponsor
385
This page
747
matching current filters
Co-sponsor SB 1043
In committee · Oregon Senate · Co-sponsor
Relating to expenses of foster children.

Directs Department of Human Services to provide reimbursements for transportation expenses incurred on behalf of foster child if expenses are related to child's continuing participation in extracurricular activities child engaged in prior to child's placement in foster home or child-caring agency.

In committee Jul 1, 2019 1 co-sponsor
Co-sponsor HB 2301
In committee · Oregon House · Co-sponsor
Relating to wine.

Allows Oregon Liquor Control Commission to enter into interstate agreements with agencies of other states for purpose of ensuring multistate enforcement of standards for wine consistent with standards of state where wine was produced.

In committee Jul 1, 2019 1 co-sponsor
Primary HB 2332
In committee · Oregon House · Lead sponsor
Relating to Governor's Child Foster Care Advisory Commission.

Directs Governor ] Department of Human Services to provide staff support , including full-time equivalent policy analyst, for Governor's Child Foster Care Advisory Commission. Increases number of members on commission from 11 to 13. Modifies commission membership requirements. Directs Chief Justice of Supreme Court to appoint any member of commission who is representative of Judicial Department. Appropriates moneys to commission for compensation and expense reimbursement for commission members.

In committee Jul 1, 2019 0 co-sponsors
Co-sponsor SB 872
In committee · Oregon Senate · Co-sponsor
Relating to the cost of prescription drugs.

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of ] amount of money spent on patient assistance programs , and ] information on financial assistance provided to pharmacies, government agencies and advocacy organizations and total amount of financial incentives paid to each pharmacy benefit manager . Excludes proprietary information from disclosure on department's website. ] Exempts from public disclosure information reported to department until department posts to website all information reported by manufacturer. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs for small employer and individual health benefit plans to insurer's website. Requires 60-day advance notice to department and to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash ] retail price for drug is less than insured's cost-share ] out-of-pocket cost for drug using pharmacy benefit , insured may pay cash ] retail price and expense must be counted ] if requested by enrollee, insurer must count cost toward deductible or out-of-pocket maximum. Requires State Board of Pharmacy to prescribe by rule notice of enrollee's rights for distribution to pharmacy customers and to translate notice into multiple languages. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers ] report to Oregon Health Authority information regarding 50 most prescribed drugs and 50 most expensive drugs prescribed by provider . Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget ] annual gross receipts exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority ] specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires insurers to include with rate filing certified statement regarding insurers' use of rebates. Requires drug advertisement to disclose wholesale price of drug. ] Modifies responsibilities of Task Force on Fair Pricing of Prescription Drugs and requires report of findings, by September 15, 2020, to interim committees of Legislative Assembly related to health. Modifies reporting to department by insurers about costly drugs reimbursed by health benefit plans. Requires pharmaceutical manufacturers that register with State Board of Pharmacy to also register with department. Requires department to adopt registration fee based on reasonable cost to department to administer specified provisions.

In committee Jun 30, 2019 1 co-sponsor
Primary SB 731
Signed into law · Oregon Senate · Lead sponsor
Relating to political activity at public post-secondary institutions of education; and prescribing an effective date.

Authorizes recognized student government of community college or public university, or member of recognized student government, to make statement or issue resolution to promote or oppose gathering of signatures on initiative or referendum petition or adoption of ballot measure. Takes effect on 91st day following adjournment sine die. .

Signed into law Jun 21, 2019 0 co-sponsors
Primary SB 917
Signed into law · Oregon Senate · Lead sponsor
Relating to employers of care providers.

Prohibits long term care facilities, residential facilities, adult foster homes, child care facilities, child-caring agencies, foster homes, youth care centers, youth offender foster homes or other entities that are licensed, certified or registered to provide care to children, youth, individuals with disabilities or older adults from interfering with good faith disclosure of information by employees or volunteers about abuse or mistreatment of individuals cared for by entity, violations of state or federal laws or other practice that threatens health and safety of individuals cared for by entity, to regulatory agencies, law enforcement authorities, persons acting on behalf of individual and other specified individuals. Makes interfering with disclosure of information specified in Act unlawful employment practice.

Signed into law Jun 21, 2019 0 co-sponsors
Showing 561 to 570 of 747 bills
Previous 1 … 56 57 58 … 75 Next